Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Kammertöns, Thomas Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (2) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (15) (-) Selbach, Matthias Prof. Dr. (5) Biologie maligner Lymphome (2) Entwicklungsneurobiologie (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (15) (-) Proteom Dynamik (5) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) (-) 1998 (9) 1999 (4) 2000 (8) (-) 2001 (8) 2002 (8) 2003 (10) 2004 (10) 2005 (14) (-) 2006 (3) 2007 (6) 2008 (8) 2009 (8) 2010 (10) 2011 (12) 2012 (10) 2013 (15) 2014 (15) 2015 (13) 2016 (12) 2017 (12) 2018 (10) 2019 (11) 2020 (6) 2021 (16) 2022 (16) 2023 (8) 2024 (4) 20 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Selbach, Matthias Prof. Dr.Molekulare Immunologie und Gentherapie Proteom Dynamik199820012006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Januar 2001 / Canc Res Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber 01. Januar 2001 / Eur J Immunol Decreased generation of anti-tumor immunity after intrasplenic immunization S. Cayeux Z.H. Qin B. Doerken T. Blankenstein 01. Januar 2001 / Nat Med Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay C. Becker H. Pohla B. Frankenberger T. Schueler M. Assenmacher D.J. Schendel T. Blankenstein 03. Dezember 2001 / J Exp Med Tumor rejection by disturbing tumor stroma cell interactions S. Ibe Z.H. Qin T. Schueler S. Preiss T. Blankenstein 17. Dezember 2001 / J Exp Med Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8+ T cells T. Schueler T. Kammertoens S. Preiss P. Debs N. Noben-Trauth T. Blankenstein 01. Januar 1998 / Adv Exp Med Biol Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosis P.T. Daniel A. Kroidl S. Cayeux C. Scholz I. Sturm T. Blankenstein A. Pezzutto B. Doerken 01. September 1998 / J Immunol Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-11 M. Petersson J. Charo F. Salazar-Onfray G. Noffz M. Mohaupt Z.H. Qin G. Klein T. Blankenstein R. Kiessling 01. Januar 1998 / Hum Gene Ther Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-restricted CTL response against selectable marker genes D. Jung E. Jaeger S. Cayeux T. Blankenstein C. Hilmes J. Karbach U. Moebius A. Knuth C. Huber B. Seliger 01. Januar 1998 / J Immunol Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors G. Noffz Z.H. Qin M. Kopf T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Januar 2001 / Canc Res Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber
01. Januar 2001 / Eur J Immunol Decreased generation of anti-tumor immunity after intrasplenic immunization S. Cayeux Z.H. Qin B. Doerken T. Blankenstein
01. Januar 2001 / Nat Med Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay C. Becker H. Pohla B. Frankenberger T. Schueler M. Assenmacher D.J. Schendel T. Blankenstein
03. Dezember 2001 / J Exp Med Tumor rejection by disturbing tumor stroma cell interactions S. Ibe Z.H. Qin T. Schueler S. Preiss T. Blankenstein
17. Dezember 2001 / J Exp Med Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8+ T cells T. Schueler T. Kammertoens S. Preiss P. Debs N. Noben-Trauth T. Blankenstein
01. Januar 1998 / Adv Exp Med Biol Retroviral B7.1 gene transfer in cancer cells protects cytotoxic T cells from deletion by "veto" apoptosis P.T. Daniel A. Kroidl S. Cayeux C. Scholz I. Sturm T. Blankenstein A. Pezzutto B. Doerken
01. September 1998 / J Immunol Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-11 M. Petersson J. Charo F. Salazar-Onfray G. Noffz M. Mohaupt Z.H. Qin G. Klein T. Blankenstein R. Kiessling
01. Januar 1998 / Hum Gene Ther Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-restricted CTL response against selectable marker genes D. Jung E. Jaeger S. Cayeux T. Blankenstein C. Hilmes J. Karbach U. Moebius A. Knuth C. Huber B. Seliger
01. Januar 1998 / J Immunol Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors G. Noffz Z.H. Qin M. Kopf T. Blankenstein